These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 17258770)
21. Intracranial large artery disease among OCSP subtypes in ethnic South Asian ischemic stroke patients. De Silva DA; Woon FP; Pin LM; Chen CP; Chang HM; Wong MC J Neurol Sci; 2007 Sep; 260(1-2):147-9. PubMed ID: 17524424 [TBL] [Abstract][Full Text] [Related]
22. Safety and efficacy of desmoteplase given 3-9 h after ischaemic stroke in patients with occlusion or high-grade stenosis in major cerebral arteries (DIAS-3): a double-blind, randomised, placebo-controlled phase 3 trial. Albers GW; von Kummer R; Truelsen T; Jensen JK; Ravn GM; Grønning BA; Chabriat H; Chang KC; Davalos AE; Ford GA; Grotta J; Kaste M; Schwamm LH; Shuaib A; Lancet Neurol; 2015 Jun; 14(6):575-84. PubMed ID: 25937443 [TBL] [Abstract][Full Text] [Related]
23. Correlation between symptomatic, radiological and etiological diagnosis in acute ischemic stroke. Tei H; Uchiyama S; Koshimizu K; Kobayashi M; Ohara K Acta Neurol Scand; 1999 Mar; 99(3):192-5. PubMed ID: 10100964 [TBL] [Abstract][Full Text] [Related]
24. Effect of baseline magnetic resonance imaging (MRI) apparent diffusion coefficient lesion volume on functional outcome in ischemic stroke. Ma L; Gao PY; Hu QM; Lin Y; Jing LN; Xue J; Chen ZJ; Wang YJ; Liu ML; Cai YF Neurol Res; 2011 Jun; 33(5):494-502. PubMed ID: 21669118 [TBL] [Abstract][Full Text] [Related]
25. Early administration of aspirin in patients treated with alteplase for acute ischaemic stroke: a randomised controlled trial. Zinkstok SM; Roos YB; Lancet; 2012 Aug; 380(9843):731-7. PubMed ID: 22748820 [TBL] [Abstract][Full Text] [Related]
26. Early Anticipation of Candidacy for Intra-Arterial Reperfusion Therapy Based on Baseline Clinical Stroke Subtypes: Comparison with Multiparametric MRI Taken within 4.5 Hours from Stroke Onset. Kim YW; Kang DH; Hwang YH; Kim YS; Park SP Cerebrovasc Dis Extra; 2013 Jan; 3(1):85-94. PubMed ID: 23885261 [TBL] [Abstract][Full Text] [Related]
27. Preclusion of ischemic stroke patients from intravenous tissue plasminogen activator treatment for mild symptoms should not be based on low National Institutes of Health Stroke Scale Scores. Wendt M; Tütüncü S; Fiebach JB; Scheitz JF; Audebert HJ; Nolte CH J Stroke Cerebrovasc Dis; 2013 May; 22(4):550-3. PubMed ID: 23433783 [TBL] [Abstract][Full Text] [Related]
28. The Oxfordshire Community Stroke Project classification: correlation with imaging, associated complications, and prediction of outcome in acute ischemic stroke. Pittock SJ; Meldrum D; Hardiman O; Thornton J; Brennan P; Moroney JT J Stroke Cerebrovasc Dis; 2003 Jan; 12(1):1-7. PubMed ID: 17903897 [TBL] [Abstract][Full Text] [Related]
29. Relationship between pattern of intracranial artery abnormalities on transcranial doppler and Oxfordshire Community Stroke Project clinical classification of ischemic stroke. Mead GE; Wardlaw JM; Dennis MS; Lewis SC; Warlow CP Stroke; 2000 Mar; 31(3):714-9. PubMed ID: 10700509 [TBL] [Abstract][Full Text] [Related]
30. Prestroke physical activity is associated with good functional outcome and arterial recanalization after stroke due to a large vessel occlusion. Ricciardi AC; López-Cancio E; Pérez de la Ossa N; Sobrino T; Hernández-Pérez M; Gomis M; Munuera J; Muñoz L; Dorado L; Millán M; Dávalos A; Arenillas JF Cerebrovasc Dis; 2014; 37(4):304-11. PubMed ID: 24851928 [TBL] [Abstract][Full Text] [Related]
31. Rehabilitation in patients affected by different types of stroke. A one-year follow-up study. Lauretani F; Saccavini M; Zaccaria B; Agosti M; Zampolini M; Franceschini M; Eur J Phys Rehabil Med; 2010 Dec; 46(4):511-6. PubMed ID: 20414185 [TBL] [Abstract][Full Text] [Related]
32. Statin use and functional outcome after tissue plasminogen activator treatment in acute ischaemic stroke. Miedema I; Uyttenboogaart M; Koopman K; De Keyser J; Luijckx GJ Cerebrovasc Dis; 2010 Feb; 29(3):263-7. PubMed ID: 20090317 [TBL] [Abstract][Full Text] [Related]
33. [A prospective study for systemic inflammatory response syndrome (SIRS) after cerebral infarction]. Xue YY; Xu XY; Li G; Wang Y Zhonghua Nei Ke Za Zhi; 2008 Dec; 47(12):988-90. PubMed ID: 19134300 [TBL] [Abstract][Full Text] [Related]
34. Validation of a clinical classification for subtypes of acute cerebral infarction. Anderson CS; Taylor BV; Hankey GJ; Stewart-Wynne EG; Jamrozik KD J Neurol Neurosurg Psychiatry; 1994 Oct; 57(10):1173-9. PubMed ID: 7931376 [TBL] [Abstract][Full Text] [Related]
35. Is the benefit of early recanalization sustained at 3 months? A prospective cohort study. Labiche LA; Al-Senani F; Wojner AW; Grotta JC; Malkoff M; Alexandrov AV Stroke; 2003 Mar; 34(3):695-8. PubMed ID: 12624293 [TBL] [Abstract][Full Text] [Related]
37. Community-based thrombolytic therapy of acute ischemic stroke in Helsinki. Lindsberg PJ; Soinne L; Roine RO; Salonen O; Tatlisumak T; Kallela M; Häppölä O; Tiainen M; Haapaniemi E; Kuisma M; Kaste M Stroke; 2003 Jun; 34(6):1443-9. PubMed ID: 12738891 [TBL] [Abstract][Full Text] [Related]
38. Rate, degree, and predictors of recovery from disability following ischemic stroke. Hankey GJ; Spiesser J; Hakimi Z; Bego G; Carita P; Gabriel S Neurology; 2007 May; 68(19):1583-7. PubMed ID: 17485645 [TBL] [Abstract][Full Text] [Related]
39. Clinical diagnosis of lacunar stroke in the first 6 hours after symptom onset: analysis of data from the glycine antagonist in neuroprotection (GAIN) Americas trial. Phillips SJ; Dai D; Mitnitski A; Gubitz GJ; Johnston KC; Koroshetz WJ; Furie KL; Black S; Heiselman DE; Stroke; 2007 Oct; 38(10):2706-11. PubMed ID: 17717313 [TBL] [Abstract][Full Text] [Related]
40. DP-b99, a membrane-activated metal ion chelator, as neuroprotective therapy in ischemic stroke. Diener HC; Schneider D; Lampl Y; Bornstein NM; Kozak A; Rosenberg G Stroke; 2008 Jun; 39(6):1774-8. PubMed ID: 18403736 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]